Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06563752
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-19
Brief Title:
Exploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patients With Schizophrenia and Their Primary Caregivers
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Exploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patients With Schizophrenia and Their Primary Caregivers
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate the relationship between illness insight self-stigma in patients with schizophrenia and the awareness and associated stigma experienced by their families as well as the predictors of these factors The study will use information technology strategies for educational purposes specifically employing 3D glasses for delivering this education The goal is to develop a disease adaptation program that involves both patients and their families helping to enhance disease awareness and improve stigma experiences
Detailed Description:
Background Research has confirmed that family members of patients with schizophrenia often lack awareness of the illness and are affected by stigma leading them to be reluctant to seek help This reluctance impacts patients medication adherence increases the severity of the illness and results in recurrent episodes and deteriorating social functioning In Chinese societies where maintaining face is important the caregiving burden on families and associated stigma are even more pronounced In Taiwan there is a lack of interventions using virtual reality for family members
Objective To evaluate the effectiveness of a digital anti-stigma therapy in improving illness awareness and reducing associated stigma among patients with schizophrenia and their family members
Methods This pioneering study employs a randomized controlled trial design involving 180 patients with schizophrenia and their family members from psychiatric medical institutions in northern Taiwan Participants are randomly assigned to two groups one receiving standard care and the other receiving standard care plus VR video intervention Research tools include questionnaires on illness awareness family and patient versions internalized stigma scales and family-associated internalized stigma scales Data collection occurs at baseline immediately post-intervention and three months later The t-test and χ2 test are used to assess group homogeneity and generalized estimating equations are applied to explore the effectiveness of the intervention after controlling for basic attributes
Expected ResultsClinical Application The experimental group is anticipated to show significantly greater improvement in outcome measures compared to the control group Implementing this intervention clinically could enhance family members awareness of the illness and improve their experience of stigma thereby supporting patients in adapting to their illness and stabilizing their community living
Objective To evaluate the effectiveness of a digital anti-stigma therapy in improving illness awareness and reducing associated stigma among patients with schizophrenia and their family members
Methods This pioneering study employs a randomized controlled trial design involving 180 patients with schizophrenia and their family members from psychiatric medical institutions in northern Taiwan Participants are randomly assigned to two groups one receiving standard care and the other receiving standard care plus VR video intervention Research tools include questionnaires on illness awareness family and patient versions internalized stigma scales and family-associated internalized stigma scales Data collection occurs at baseline immediately post-intervention and three months later The t-test and χ2 test are used to assess group homogeneity and generalized estimating equations are applied to explore the effectiveness of the intervention after controlling for basic attributes
Expected ResultsClinical Application The experimental group is anticipated to show significantly greater improvement in outcome measures compared to the control group Implementing this intervention clinically could enhance family members awareness of the illness and improve their experience of stigma thereby supporting patients in adapting to their illness and stabilizing their community living
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None